Fusion Pharmaceuticals In... (FUSN)
NASDAQ: FUSN
· Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM
Fusion Pharmaceuticals Revenue
Fusion Pharmaceuticals reported an annual revenue of $2.07M, reflecting a undefined% growth. For the quarter ending March 31, 2024, Fusion Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
n/a
Revenue Growth
n/a
Price / Sales Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.83B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 2.07M | +41.55% |
| Dec 31, 2022 | 1.46M | +1.46% |
| Dec 31, 2021 | 1.44M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |